Insiders · Profile

DAVIS STEPHEN

CEO at ACADIA PHARMACEUTICALS. Filing since 9 Oct 2019. CIK 0001131146

Company

Date

Role

Action

Shares

Amount

Of holding

ACAD ACADIA PHARMACEUTICALS INC

19 Aug 2024

CEO

Sold at will

31,747

$485.09K

14.5%

ACAD ACADIA PHARMACEUTICALS INC

2 May 2024

CEO

Sold at will

11,427

$193.57K

6.9%

ACAD ACADIA PHARMACEUTICALS INC

8 Apr 2024

CEO

Sold at will

26,574

$474.88K

15.6%

ACAD ACADIA PHARMACEUTICALS INC

27 Mar 2024

CEO

Sold at will

17,714

$317.08K

13.0%

ACAD ACADIA PHARMACEUTICALS INC

26 Feb 2024

CEO

Sold at will

5,577

$137.58K

5.2%

ACAD ACADIA PHARMACEUTICALS INC

8 Jan 2024

CEO

Sold at will

3,732

$111.81K

3.7%

ACAD ACADIA PHARMACEUTICALS INC

6 Oct 2023

CEO

Sold at will

51,563

$1.13M

36.6%

ACAD ACADIA PHARMACEUTICALS INC

14 Jul 2023

CEO

Sold on a plan

100,000

$3.00M

73.2%

ACAD ACADIA PHARMACEUTICALS INC

12 Jul 2023

CEO

Sold on a plan

55,104

$1.38M

60.0%

ACAD ACADIA PHARMACEUTICALS INC

11 Jul 2023

CEO

Sold on a plan

16,498

$412.45K

15.2%

ACAD ACADIA PHARMACEUTICALS INC

1 May 2023

CEO

Sold at will

7,806

$165.33K

6.7%

ACAD ACADIA PHARMACEUTICALS INC

6 Apr 2023

CEO

Sold at will

8,582

$155.85K

7.9%

ACAD ACADIA PHARMACEUTICALS INC

24 Feb 2023

CEO

Sold, plan not stated

3,851

$72.32K

4.0%

ACAD ACADIA PHARMACEUTICALS INC

9 Jan 2023

CEO

Sold, plan not stated

3,904

$66.88K

4.4%

ACAD ACADIA PHARMACEUTICALS INC

15 Oct 2022

CEO

Sold, plan not stated

2,804

$44.33K

3.4%

ACAD ACADIA PHARMACEUTICALS INC

2 May 2022

CEO

Sold, plan not stated

5,483

$99.69K

6.7%

ACAD ACADIA PHARMACEUTICALS INC

23 Feb 2022

CEO

Sold, plan not stated

3,928

$93.49K

5.6%

ACAD ACADIA PHARMACEUTICALS INC

6 Jan 2022

CEO

Sold, plan not stated

3,718

$85.70K

6.0%

ACAD ACADIA PHARMACEUTICALS INC

18 Oct 2021

CEO

Sold, plan not stated

2,963

$51.59K

5.3%

ACAD ACADIA PHARMACEUTICALS INC

30 Apr 2021

CEO

Sold, plan not stated

7,850

$159.59K

13.7%

ACAD ACADIA PHARMACEUTICALS INC

4 Feb 2021

CEO

Sold, plan not stated

14,195

$718.41K

32.9%

ACAD ACADIA PHARMACEUTICALS INC

6 Jan 2021

CEO

Sold, plan not stated

3,484

$185.84K

12.5%

ACAD ACADIA PHARMACEUTICALS INC

16 Oct 2020

CEO

Sold, plan not stated

2,960

$125.98K

16.7%

ACAD ACADIA PHARMACEUTICALS INC

14 May 2020

CEO

Sold, plan not stated

88,542

$4.04M

88.2%

ACAD ACADIA PHARMACEUTICALS INC

13 May 2020

CEO

Sold, plan not stated

111,458

$5.17M

90.4%

ACAD ACADIA PHARMACEUTICALS INC

30 Apr 2020

CEO

Sold, plan not stated

6,770

$333.15K

36.4%

ACAD ACADIA PHARMACEUTICALS INC

5 Dec 2019

CEO

Sold, plan not stated

150,000

$7.85M

98.1%

ACAD ACADIA PHARMACEUTICALS INC

15 Oct 2019

CEO

Sold, plan not stated

2,983

$118.28K

50.2%

ACAD ACADIA PHARMACEUTICALS INC

10 Oct 2019

CEO

Sold, plan not stated

120,208

$4.83M

100%

ACAD ACADIA PHARMACEUTICALS INC

9 Oct 2019

CEO

Sold, plan not stated

29,792

$1.19M

100%

30 decisions on file.